Skip to main content

Day: October 15, 2020

Profound Medical to Release Third Quarter 2020 Financial Results on November 5 – Conference Call to Follow

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, will announce its third quarter 2020 financial results after market close on Thursday, November 5, 2020.Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.Third Quarter 2020 Results Conference Call Details:The call will also be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section.About Profound Medical...

Continue reading

BigCommerce to Announce Third Quarter 2020 Financial Results on November 5, 2020

AUSTIN, Texas, Oct. 15, 2020 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading software as-a-service (SaaS) ecommerce platform that empowers merchants of all sizes to build, innovate and grow their businesses online, today announced that it will report its financial results for the third quarter ended September 30, 2020 after market close on Thursday, November 5, 2020.The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. CT (5:00 p.m. ET) on Thursday, November 5, 2020. The conference call can be accessed by dialing (833) 519-1347 from the United States and Canada or (914) 800-3909 internationally with conference ID 3834549. The live webcast of the conference call can be accessed from BigCommerce’s investor relations website at...

Continue reading

American River Bankshares Schedules its Quarterly Conference Call

SACRAMENTO, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) — American River Bankshares (NASDAQ-GS: AMRB) today announced that it will host a conference call on Thursday, October 22, 2020 at 1:30 p.m. Pacific Time to discuss the third quarter 2020 financial results.David E. Ritchie, Jr., President and Chief Executive Officer, and Mitchell A. Derenzo, Executive Vice President and Chief Financial Officer, both of American River Bankshares, will lead a live presentation and answer analysts’ questions.Shareholders, analysts and other interested parties are invited to join the call by dialing (888) 517-2513 and entering the Conference ID 8786 097#. A replay of the call will be available approximately twenty-four hours after the completion of the call on AmericanRiverBank.com.Third quarter 2020 financial results are scheduled to be released at...

Continue reading

MacroGenics Announces Flotetuzumab Publication in Blood Advances

ROCKVILLE, MD, Oct. 15, 2020 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced the publication of a manuscript in Blood Advances, a journal of the American Society of Hematology.  This represents the third publication of flotetuzumab data in 2020. Flotetuzumab (also known as MGD006), is an investigational, clinical-stage bispecific DART® molecule that recognizes both CD123 on leukemic cells and CD3 on T cells, with the intended result of T-cell-mediated killing of leukemic blasts. This most recent publication reports on the role of flotetuzumab in the immunotherapy of TP53-positive acute myeloid leukemia (AML).It has previously been shown1 that an inflammatory...

Continue reading

Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 15, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader in cell therapy to treat cancer is aware of the early release of the abstract entitled “Initial safety, efficacy, and product attributes from the SURPASS trial with ADPA2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor” by the Society for the Immunotherapy of Cancer (“SITC”) Conference.The full abstract is attached to this release.The Company will update on the full dose escalation cohort of the SURPASS trial (6 patients in total) at the virtual SITC conference on November 11, 2020 at 9 AM EST when posters are made available online.About AdaptimmuneAdaptimmune is a clinical-stage biopharmaceutical company focused on the development...

Continue reading

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results

OLDSMAR, Fla., Oct. 15, 2020 (GLOBE NEWSWIRE) — Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2020.Financial ResultsRevenue        Consolidated revenues for the third quarter of fiscal 2020 were $8.1 million compared to $8.2 million for the third quarter of fiscal 2019. The revenues for the third quarter of fiscal 2020 consisted of $7.5 million in processing and storage fees, $427,874 in licensee income, $82,800 in product revenue and $116,826 in public banking revenue compared $7.6 million in processing and storage fees, $423,173 in licensee income, $33,035 in product revenue and $160,561 in public banking revenue for the third quarter of fiscal...

Continue reading

Credicorp Ltd.: Credicorp’s “3Q20 quiet period”

Lima, Oct. 15, 2020 (GLOBE NEWSWIRE) — Lima, PERU, October 15, 2020 — Credicorp (NYSE: BAP) announces that in accordance with its corporate disclosure policies and to prevent any leaks of financial results and ensure fairness, the Company will start the quiet period for 3Q20’s earnings release on October 22. This period will end on the date of the release, November 05. During the quiet period, the Company will not disclose any financial information, comment on financial results, or respond to related questions.About CredicorpCredicorp Ltd. (NYSE: BAP) is the leading financial services holding company in Peru with presence in Chile, Colombia and Bolivia. Credicorp has a diversified business portfolio organized into four lines of business: Universal Banking, through Banco de Credito del Peru – BCP and Banco de Credito...

Continue reading

Mettler-Toledo International Inc. to Host Third Quarter 2020 Earnings Conference Call

Columbus, OH, Oct. 15, 2020 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced it will host a conference call to discuss the Company’s quarterly results on Thursday, November 5, 2020 at 5:00 p.m. Eastern Time. To hear a live webcast of the call, visit www.mt.com/investors on the Company’s website. A replay of the webcast will be available until November 9, 2020.        METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences,...

Continue reading

BCB Bancorp, Inc. Announces Positive Trend on Loan Deferrals

BAYONNE, N.J., Oct. 15, 2020 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), announced today their loan deferral data as of October 14, 2020 reflected strong reductions in overall loan deferrals and positive trends in customer repayments. There was a significant decrease in the amount of loans that are currently in the COVID-19 Loan Deferral Program at the Bank. The Bank is seeing favorable trends as a vast majority of customers return to their regular payment schedules.“As a community-based bank, we are pleased by the positive trends within our loan portfolio and the commitment of our staff as we’ve reduced the total percentage of loan deferrals from over 30% during second quarter of 2020 to less than 1% at October 14, 2020. The data represents that...

Continue reading

Scorpio Bulkers Inc. Announces the Sale of an Ultramax Vessel

MONACO, Oct. 15, 2020 (GLOBE NEWSWIRE) — Scorpio Bulkers Inc. (NYSE: SALT) (the “Company”) announced today that the Company has entered into an agreement with an unaffiliated third party to sell the SBI Hera, an Ultramax bulk carrier built in 2016, for approximately $18.5 million. Delivery of the vessel is expected to take place in the fourth quarter of 2020.About Scorpio Bulkers Inc.Scorpio Bulkers Inc. is a provider of marine transportation of dry bulk commodities, and is investing in the next generation of wind turbine installation vessels. Upon the completion of the announced vessel sales, Scorpio Bulkers Inc. will have an operating fleet of 46 vessels consisting of 43 wholly-owned or finance leased drybulk vessels (including 13 Kamsarmax vessels and 30 Ultramax vessels), and five time chartered-in Kamsarmax vessels. In addition...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.